* Nephros Inc NEPH.OQ NEPH.O is expected to show a fall
in
quarterly revenue when it reports results on November 2.
* The South Orange New Jersey-based company is expected to
report
a 0.8% decrease in revenue to $2.616 million from $2.64 million
a year ago, according to the mean estimate from 3 analysts,
based on Refinitiv data. The company's guidance on October 11
2022, for the period ended September 30, was for revenue of
$2.500 million.
* Refinitiv's mean analyst estimate for Nephros Inc is for
a loss
of 11 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Nephros Inc
is
$3.63, above its last closing price of $1.05.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 -0.15 -0.15 -0.12 Beat 18.9
Mar. 31 2022 -0.10 -0.11 -0.20 Missed -87.5
Dec. 31 2021 -0.11 -0.11 -0.11 Met 2.9
Sep. 30 2021 -0.10 -0.10 -0.12 Missed -14.3
Jun. -0.11 -0.11 -0.12 Missed -5.9
30 2021
Mar. 31 2021 -0.12 -0.12 -0.11 Beat 7.6
Dec. 31 2020 -0.12 -0.11 -0.08 Beat 27.3
Sep. 30 2020 -0.14 -0.14 -0.12 Beat 12.2
This summary was machine generated November 1 at 02:02 GMT. All
figures in US dollars unless otherwise stated